Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy

Overview of attention for article published in Frontiers in immunology, February 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

So far, Altmetric has seen 7 X posts from 4 X users, with an upper bound of 40,994 followers.

RT @DanZickler: Important peritoneal #Dialysis research. Not always perceived as sexy, but very important for more than 270000 PD patients…

RT @FrontImmunol: New Research: Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in P…

Important peritoneal #Dialysis research. Not always perceived as sexy, but very important for more than 270000 PD patients nonetheless. @DialysisAtHome @DialysisSaves Great cooperation with @racatar @guido_moll @JanuszWitowski and others. #COVID19

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.